Foreign entities within the body get chopped into pieces by antigen-presenting cells (APCs), which display the resulting chunks on their surface. These antigens can subsequently be recognized and bound by T cell receptors (TCRs), and the interaction between a T cell and an antigen-bearing APC eventually triggers the onset of an immune response against the antigen.
Inappropriate responses by this system, however, can give rise to disastrous medical consequences, and there is keen interest in developing more sophisticated ways to modulate how T cells react to perceived threats. “Ultimately, we would like to regulate T cell function and activation in order to overcome autoimmune diseases, allergy, or infectious diseases,” explains Takashi Saito, of the RIKEN Center for Allergy and Immunology (RCAI) in Yokohama.
New findings from a team led by Saito and RCAI colleague Tadashi Yokosuka could ultimately prove valuable for such efforts, by revealing insights into the mode of action of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), an inhibitor of TCR signaling1. When T cells associate with APCs, they form what is known as an ‘immunological synapse’, a juncture where numerous proteins assemble into elaborate complexes, such as the central supramolecular activation cluster (cSMAC). By establishing experimental conditions that simulate this cellular interaction, the researchers were able to monitor the dynamic rearrangements that take place at the cSMAC and its environs.
CD28, a T cell protein that promotes TCR signaling, typically assembles at a narrowly defined region of the cSMAC, where it interacts with CD80, a protein expressed on the surface of APCs. Saito, Yokosuka and colleagues determined that CTLA-4 gradually gathers at the immunological synapse and subsequently forms into clusters within the exact same area of the cSMAC as CD28, where it directly competes to bind CD80. “Positive regulation by CD28 and negative regulation by CTLA-4 are induced at the same place in the cell,” says Saito. “Without accumulating at the cSMAC, CTLA-4 cannot inhibit T cell activation.”
In addition to illuminating a mechanism by which T cell responses get fine-tuned, these findings could ultimately yield benefits for patients suffering from a variety of conditions. “Anti-CTLA-4 antibody therapy has been utilized for cancer patients, enhancing tumor immunity by inhibiting regulatory T cells, and CTLA-4-based fusion proteins have been used to block autoimmune diseases such as arthritis,” says Saito. “Our findings will enable us to explore new therapeutic concepts based on the inhibition of the dynamic movement of regulatory molecules such as CTLA-4.”
The corresponding author for this highlight is based at the Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology.
1.Yokosuka, T., Kobayashi, W., Takamatsu, M., Sakata-Sogawa, K., Zeng, H., Hashimoto-Tane, A., Yagita, H., Tokunaga, M. & Saito, T. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T Cell activation. Immunity 33, 326–339 (2010).
Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University
How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy